Berry Global Group, Inc. announced that it has initiated a formal process to evaluate strategic alternatives for its Health, Hygiene and Specialties segment (“HH&S”). HH&S is a leading provider of nonwovens, specialty films, and tapes for a broad range of end markets, including healthcare, hygiene, consumer, building and construction, and industrials. The segment is well-positioned in its core businesses, providing value-added products to many of the world’s leading brand owners. The Company is considering a wide range of available alternatives to maximize shareholder value, including, but not limited to, a sale, strategic partnership or joint venture, spin-off to shareholders, or other separation transaction for some or all of the businesses within HH&S. Importantly, the Company expects current members of the HH&S leadership team will continue to lead the business in any anticipated outcome.

Metsä Board aims at strengthening its position as Europe’s leading producer of folding boxboard and plans to increase its production capacity. The company has started pre-engineering for increasing the annual production capacity of folding boxboard machine BM1 at the Husum mill in Sweden by approximately 200,000 tonnes. The pre-engineering phase includes also an evaluation of the mill port’s capacity for increased volumes of raw materials and finished goods. The planned investment would further strengthen Husum BM1’s position as the biggest folding boxboard machine in Europe. The final investment decision is subject to the results of the pre-engineering phase. The readiness to make the final investment decision is expected to be achieved in the summer of 2021 and the ramp-up of the additional capacity would start in 2023.

Q4 2023 Highlights *Sales of $1,138 million (compared with $1,198 million in Q3 2023 and $1,135 million in Q4 2022); *Operating loss of $(24) million (compared with operating income of $80 million in Q3 2023 and operating loss of $(20) million in Q4 2022); 2023 Annual Highlights *Sales of $4,638 million (compared with $4,466 million in 2022); *Operating income of $40 million (compared with $33 million in 2022); *Net debt1 of $1,882 million as of December 31, 2023 (compared with $1,966 million as of December 31, 2022). Net debt to EBITDA (A) ratio1 of 3.4x, down from 5.2x as of December 31, 2022; *Total capital expenditures, net of disposals, of $46 million in Q4 2023 and $343 million in 2023. The Corporation's 2024 forecasted net capital expenditures of approximately $175 million is unchanged.